Author Correction: Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology

Correction to: Communications Medicine 10.1038/s43856-022-00209-1, published online 06 December 2022.

The data in Table 2 were erroneously duplicated in Table 3 of this article. The correct version of Table 3 is displayed below. Table 3 has been corrected in the HTML and PDF versions of this article.

Table 3.

Results obtained with the expanded drug list.

Drug	Albumin IC50		ALT		Morphology		IF imaging
	Donor 1	Donor 2	Donor 1	Donor 2	Donor 1	Donor 2	Donor 1	Donor 2
Asunaprevir	190	–	>1000	–	1000	–	Apoptosis	–
Benoxaprofen	8	20	>100	100	<0.1	100	Apoptosis	Apoptosis
Beta-Estradiol	>300	–	>300	–	>300	–	No findings	–
Chlorpheniramine	>300	–	>300	–	>300	–	No findings	–
Diclofenac	384	–	>1000	–	1000	–	Apoptosis	–
Labetalol	26	40	>100	100	>100	100	Apoptosis	Apoptosis
Lomitapide	4	–	>1000	–	<0.1	–	No findings	–
Simvastatin	<0.1	<10	>300	>300	>300	>300	No findings	Apoptosis
Stavudine	>60	132	300	>300	300	300	No findings	Mitotoxicity
Tacrine	76	>25	>300	>1000	>300	>1000	Apoptosis	Apoptosis
Telithromycin	13	–	30	–	100	–	Apoptosis	–
Ximelagatran	32	>300	30	>300	100	300	No findings	No findings
Zileuton	>100	210	>100	>300	>100	>300	No findings	No findings